[#item_full_content] A key U.S. Senate committee has released spending bills and attached reports that would keep blocking local officials in Washington, D.C. from legalizing recreational marijuana sales and direct federal officials to continue drug testing safety sensitive workers for cannabis even under rescheduling—while also recognizing the therapeutic potential of psychedelics and noting that Schedule I status  Read More